In 2024, Medicaid payments in Collegeville reached at least $4,602 for services identified in HCPCS codes directly tied to COVID-19, based on records from the U.S. Department of Health and Human Services Medicaid Provider Spending database.
As a national health program administered by states and funded through joint federal and state contributions, Medicaid assists low-income residents, seniors, children and those with disabilities. This makes it a foundational pillar of the U.S. health care landscape.
Since Medicaid dollars come from public funds, local shifts in spending mirror how a community’s health care resources are utilized.
Analysts classified COVID-19–related services with HCPCS codes marked as “COVID-19” or “coronavirus” in either their billing description or reference data. Therefore, the payment data focuses only on explicitly labeled COVID-related services and may not include broader health care responses billed under nonspecific codes.
By way of benchmark, Pittsburgh posted the highest sums in Pennsylvania for Medicaid claims connected to COVID-19 services in 2024, with a total of $266,441 in statewide virus-related spending.
Quest Diagnostics Clinical Laboratories Inc was identified as the sole Medicaid claims provider for COVID-19–related services in Collegeville for 2024.
COVID-19–specific expenditures represented a sizable portion of Medicaid’s spending increase in Collegeville at the height of the pandemic.
Payments for all other Medicaid claim types jumped by $2,286,903 from 2020 to 2024, which amounts to a 456.3% rise.
Two years prior to the onset of the pandemic, the community averaged $1,741 a year in Medicaid spending.
The Centers for Medicare & Medicaid Services report that total federal and state Medicaid outlays grew to about $871.7 billion in fiscal year 2023, approximately 18% of U.S. health expenditures, which was up from $613.5 billion in 2019 before COVID-19 started.
This approximately 40% growth over just a few years was largely fueled by greater enrollment and use both amid and after the pandemic.
Recent federal budget rules during the Trump administration featured major proposals aimed at decreasing federal Medicaid funding and revising the program’s structure. The “One Big Beautiful Bill Act,” passed in 2025, is expected to reduce federal Medicaid outlays by more than $1 trillion in the coming decade and enacts new provisions such as work requirements and greater cost-sharing by beneficiaries, with possible reductions in coverage. As a result, states could assume a greater funding share and see constrained federal support, even as a large number of people depend on the program.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $4,602 | -93% | $2,792,690 |
| 2023 | $65,348 | -86.3% | $3,768,773 |
| 2022 | $475,351 | -59% | $3,971,506 |
| 2021 | $1,158,484 | 139.1% | $4,176,257 |
| 2020 | $484,496 | N/A | $985,680 |
| 2019 | $0 | N/A | $2,102 |
| 2018 | $0 | N/A | $1,380 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87635 | COVID Specific | $4,602 | 323 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
Details in this report were sourced from the U.S. Department of Health and Human Services Medicaid Provider Spending database. See source data here.






